ECTRIMS 2022: Research Insights from Day Two

Brett Drummond (Co-founder, MStranslate) and Dr Travis Stiles (CEO, Novoron Bioscience) reflect on some of the key research outcomes presented throughout the second day of ECTRIMS 2022, the world's largest multiple sclerosis (MS) research conference. Topics covered include lifestyle interventions and modifications, remyelination, imaging, cell tracking and progressive MS. Learn more about ECTRIMS 2022 by visiting the official event website at the following link - https://2022.ectrims-congress.eu Learn more about MStranslate and follow us on our other platforms via the links below: Website: https://mstranslate.com.au​​​​​​ Facebook:   / mstranslate​   Twitter:   / mstranslate​​​​​​   Instagram:   / mstranslate​   LinkedIn:   / mstranslate